Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid
- PMID: 30017319
- PMCID: PMC6137024
- DOI: 10.1016/j.bmcl.2018.07.016
Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid
Abstract
Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78 µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.
Keywords: Acinetobacter baumannii; Antimicrobial; Hydrazone; MRSA; Pyrazole.
Published by Elsevier Ltd.
Figures
Similar articles
-
Synthesis and Antimicrobial Studies of 4-[3-(3-Fluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic Acid and 4-[3-(4-Fluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic Acid as Potent Growth Inhibitors of Drug-Resistant Bacteria.ACS Omega. 2019 Aug 21;4(10):14284-14293. doi: 10.1021/acsomega.9b01967. eCollection 2019 Sep 3. ACS Omega. 2019. PMID: 31508552 Free PMC article.
-
Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureus.J Antibiot (Tokyo). 2020 Dec;73(12):818-827. doi: 10.1038/s41429-020-0341-2. Epub 2020 Jun 29. J Antibiot (Tokyo). 2020. PMID: 32601342 Free PMC article.
-
Synthesis of Hydrazone Derivatives of 4-[4-Formyl-3-(2-oxochromen-3-yl)pyrazol-1-yl]benzoic acid as Potent Growth Inhibitors of Antibiotic-resistant Staphylococcus aureus and Acinetobacter baumannii.Molecules. 2019 May 29;24(11):2051. doi: 10.3390/molecules24112051. Molecules. 2019. PMID: 31146470 Free PMC article.
-
Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agents.Bioorg Med Chem Lett. 2017 Feb 1;27(3):387-392. doi: 10.1016/j.bmcl.2016.12.068. Epub 2016 Dec 29. Bioorg Med Chem Lett. 2017. PMID: 28065568 Free PMC article.
-
Hydrazide-hydrazones of 3-methoxybenzoic acid and 4-tert-butylbenzoic acid with promising antibacterial activity against Bacillus spp.J Enzyme Inhib Med Chem. 2016;31(sup1):62-69. doi: 10.3109/14756366.2016.1170012. Epub 2016 Apr 13. J Enzyme Inhib Med Chem. 2016. PMID: 27075005
Cited by
-
Pyrazole: an emerging privileged scaffold in drug discovery.Future Med Chem. 2023 Nov;15(21):2011-2023. doi: 10.4155/fmc-2023-0207. Epub 2023 Nov 7. Future Med Chem. 2023. PMID: 37933613 Free PMC article. Review.
-
Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents.Molecules. 2020 Jun 15;25(12):2758. doi: 10.3390/molecules25122758. Molecules. 2020. PMID: 32549248 Free PMC article.
-
Synthesis and Antimicrobial Studies of 4-[3-(3-Fluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic Acid and 4-[3-(4-Fluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic Acid as Potent Growth Inhibitors of Drug-Resistant Bacteria.ACS Omega. 2019 Aug 21;4(10):14284-14293. doi: 10.1021/acsomega.9b01967. eCollection 2019 Sep 3. ACS Omega. 2019. PMID: 31508552 Free PMC article.
-
Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureus.J Antibiot (Tokyo). 2020 Dec;73(12):818-827. doi: 10.1038/s41429-020-0341-2. Epub 2020 Jun 29. J Antibiot (Tokyo). 2020. PMID: 32601342 Free PMC article.
-
Antibacterial pyrazoles: tackling resistant bacteria.Future Med Chem. 2022 Mar;14(5):343-362. doi: 10.4155/fmc-2021-0275. Epub 2022 Jan 20. Future Med Chem. 2022. PMID: 35050719 Free PMC article. Review.
References
-
- Friedrich MJ. Who survey reveals misconceptions about antibiotic resistance. JAMA. 2016;315:242.
-
- CDC Antibiotic/Antimicrobial Resistance. https://www.cdc.gov/drugresistance/federal-engagement-in-ar/national-str... (accessed 10/19/2016).
-
- Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1–12. - PubMed
-
- CDC Acinetobacter in Healthcare Settings. Acinetobacter in Healthcare Settings (accessed 9/22/2016).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical